Safety and immunogenicity of investigational herpes simplex virus-2 vaccines in adults with recurrent genital infection. Laing KJ, Sholukh AM, MacPhee KJ, McClurkan CL, et al. Vaccine 2025;65:127821.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Laing KJ, Sholukh AM, MacPhee KJ, McClurkan CL, et al. Safety and immunogenicity of investigational herpes simplex virus-2 vaccines in adults with recurrent genital infection. Vaccine 2025;65:127821.
PMID: 41056754